GSE125500
Identifying Tumor Progression by Genome-Wide Characterization of Immature Myeloid Cells In the Peripheral Blood
characterize the molecular signature of PB-IMC in different stages of tumor development, thus possibly leading to a novel, sensitive and elegant approach for early cancer detection and surveillance. Overall design: Two types of cancer. For each type 4 groups (day 0, day 4, day 8, day 11), for each group 3 biological repeats